Ignite Creation Date:
2024-05-06 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05204433
Status:
UNKNOWN
Last Update Posted:
2022-01-24
First Post:
2022-01-11
Brief Title:
Correlation Between SFRP1 and Colorectal Cancer and Adenoma
Sponsor:
Xijing Hospital of Digestive Diseases
Organization:
Xijing Hospital of Digestive Diseases
Study Overview
Official Title:
Correlation Between Methylation Site of SFRP1 Gene Promoter and Colorectal Cancer and Adenoma
Status:
UNKNOWN
Status Verified Date:
2022-01
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In summary our study demonstrated the methylation sites of SFRP1 gene promoter in patients with colorectal cancer and adenoma and found SFRP1_16_17_18 CpG site was good performance as a diagnostic marker of colorectal cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None